Cadherin–catenin complex dissociation in lobular neoplasia of the breast

[1]  Yao-Tseng Chen,et al.  Clonal relationship between closely approximated low-grade ductal and lobular lesions in the breast: a molecular study of 10 cases. , 2009, American journal of clinical pathology.

[2]  S. Alahari,et al.  Molecular mechanisms controlling E-cadherin expression in breast cancer. , 2009, Biochemical and biophysical research communications.

[3]  P. Guilford,et al.  Epigenetic silencing in non‐neoplastic epithelia identifies E‐cadherin (CDH1) as a target for chemoprevention of lobular neoplasia , 2009, The Journal of pathology.

[4]  S. Dhanasekaran,et al.  Repression of E-cadherin by the polycomb group protein EZH2 in cancer , 2008, Oncogene.

[5]  Md Isa Nurismah,et al.  E-cadherin expression correlates with histologic type but not tumour grade in invasive breast cancer. , 2008, Asian Pacific journal of cancer prevention : APJCP.

[6]  R. Mansel,et al.  Real time PCR analyses of expression of E-cadherin, alpha-, beta- and gamma-catenin in human breast cancer for predicting clinical outcome , 2008, World journal of surgical oncology.

[7]  W. Birchmeier,et al.  Wnt signalling and its impact on development and cancer , 2008, Nature Reviews Cancer.

[8]  S. Lakhani,et al.  Aberrant Expression of E-cadherin in Lobular Carcinomas of the Breast , 2008, The American journal of surgical pathology.

[9]  I. Ellis,et al.  Morphologic and Molecular Evolutionary Pathways of Low Nuclear Grade Invasive Breast Cancers and Their Putative Precursor Lesions: Further Evidence to Support the Concept of Low Nuclear Grade Breast Neoplasia Family , 2008, The American journal of surgical pathology.

[10]  P. V. van Diest,et al.  Twist is a transcriptional repressor of E-cadherin gene expression in breast cancer. , 2008, Biochemical and biophysical research communications.

[11]  P. Schirmacher,et al.  Clonality of lobular carcinoma in situ (LCIS) and metachronous invasive breast cancer , 2008, Breast Cancer Research and Treatment.

[12]  Teresa L. Mastracci,et al.  Genomics and premalignant breast lesions: clues to the development and progression of lobular breast cancer , 2007, Breast Cancer Research.

[13]  P. Miron,et al.  Germline E-cadherin mutations in familial lobular breast cancer , 2007, Journal of Medical Genetics.

[14]  Narciso Olvera,et al.  Tissue preparation for laser capture microdissection and RNA extraction from fresh frozen breast tissue. , 2007, BioTechniques.

[15]  I. Ellis,et al.  High Frequency of Coexistence of Columnar Cell Lesions, Lobular Neoplasia, and Low Grade Ductal Carcinoma In Situ With Invasive Tubular Carcinoma and Invasive Lobular Carcinoma , 2007, The American journal of surgical pathology.

[16]  C. Theillet,et al.  Snail and Slug Play Distinct Roles during Breast Carcinoma Progression , 2006, Clinical Cancer Research.

[17]  M. Bracken,et al.  E-cadherin Immunohistochemical Expression as a Prognostic Factor in Infiltrating Ductal Carcinoma of the Breast: a Systematic Review and Meta-Analysis , 2006, Breast Cancer Research and Treatment.

[18]  V. Eusebi,et al.  Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast , 2006, Virchows Archiv.

[19]  Cláudia A Rainho,et al.  CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer , 2006, BMC Cancer.

[20]  P. Eilers,et al.  E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines , 2006, British Journal of Cancer.

[21]  J. Nesland,et al.  Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma , 2005, Cancer.

[22]  S. Lakhani,et al.  Molecular evolution of breast cancer , 2005, The Journal of pathology.

[23]  S. Ramaswamy,et al.  Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis , 2004, Cell.

[24]  S. Devries,et al.  Clonality of lobular carcinoma in situ and synchronous invasive lobular carcinoma , 2004, Cancer.

[25]  Douglas R Lowy,et al.  E‐cadherin‐mediated adhesion inhibits ligand‐dependent activation of diverse receptor tyrosine kinases , 2004, The EMBO journal.

[26]  Gordon K Smyth,et al.  Statistical Applications in Genetics and Molecular Biology Linear Models and Empirical Bayes Methods for Assessing Differential Expression in Microarray Experiments , 2011 .

[27]  J. Herman,et al.  Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: Relationships with abnormal E‐cadherin and catenin expression and microsatellite instability , 2003, International journal of cancer.

[28]  G. Moreno-Bueno,et al.  Correlation of Snail expression with histological grade and lymph node status in breast carcinomas , 2002, Oncogene.

[29]  A. Cleton-Jansen.  E-cadherin and loss of heterozygosity at chromosome 16 in breast carcinogenesis: different genetic pathways in ductal and lobular breast cancer? , 2001, Breast Cancer Research.

[30]  R. Roylance,et al.  Multiple ways of silencing E‐cadherin gene expression in lobular carcinoma of the breast , 2001, International journal of cancer.

[31]  K. Rieger-Christ,et al.  Disparate E-cadherin mutations in LCIS and associated invasive breast carcinomas , 2001, Molecular pathology : MP.

[32]  N. Kohno,et al.  Decreased E-cadherin augments beta-catenin nuclear localization: studies in breast cancer cell lines. , 2001, International journal of oncology.

[33]  W. Jiang,et al.  E-cadherin complex and its abnormalities in human breast cancer. , 2000, Surgical oncology.

[34]  S. Seal,et al.  Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene , 2000, British Journal of Cancer.

[35]  G. Berx,et al.  The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. , 1999, Molecular cell biology research communications : MCBRC.

[36]  M. J. van de Vijver,et al.  Simultaneous loss of E‐cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ , 1997, The Journal of pathology.

[37]  G. Berx,et al.  E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. , 1996, Oncogene.

[38]  T. Ohta,et al.  Expression of β‐catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and α‐catenin , 1996 .

[39]  M. Vijver,et al.  E‐cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. , 1995, The EMBO journal.

[40]  Anthony Rhodes,et al.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. , 2007, Archives of pathology & laboratory medicine.

[41]  T. Rebbeck,et al.  Differential expression of E-cadherin in lobular and ductal neoplasms of the breast and its biologic and diagnostic implications. , 2001, American journal of clinical pathology.

[42]  T. Ohta,et al.  Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. , 1996, Histopathology.